|
|
|
|
||
|
(State or other jurisdiction
of incorporation or organization)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
|
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
|
Emerging growth company
|
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
◻
|
|
Exhibits
|
Description of Exhibits
|
|
|
Registrant's Press Release dated May 5, 2022*
|
||
|
U.S. PHYSICAL THERAPY, INC.
|
|||||||
|
Dated: May 5, 2022
|
By:
|
/s/ CAREY HENDRICKSON
|
|||||
|
Carey Hendrickson
|
|||||||
|
Chief Financial Officer
|
|||||||
|
(duly authorized officer and principal financial and accounting officer)
|
|||||||
|
•
|
Operating Results per diluted share, a non-GAAP measure (defined below), was $0.65 per diluted share for the 2022 First Quarter as
compared to $0.64 for the three months ended March 31, 2021 (“2021 First Quarter”).
|
|
•
|
For the 2022 First Quarter, USPH’s net income attributable to its shareholders, a Generally Accepted Accounting Principles (“GAAP”)
measure, was $8.8 million compared to $8.2 million for the 2021 First Quarter. GAAP requires the Company to include a charge for the revaluation of its non-controlling interest, net of taxes, in its computation of earnings per diluted
share. Earnings per diluted share on a GAAP basis, was $0.67 for the 2022 First Quarter as compared to $0.21 for the 2021 First Quarter.
|
|
•
|
Adjusted EBITDA, a non-GAAP measure (defined below), was $17.9 million for the 2022 First Quarter, a 14.2% increase from $15.6 million
for the 2021 First Quarter. See pages 10 through 11 for a discussion and reconciliation to results according to GAAP.
|
|
•
|
Average visits per clinic per day in the 2022 First Quarter was 27.9, up from 27.1 in the 2021 First Quarter.
|
|
•
|
Total patient visits were 1,063,519 for the 2022 First Quarter, an increase of 12.2% from 947,788 for the 2021 First Quarter. On a
same store basis, visits increased 5.9% in the 2022 First Quarter as compared to the 2021 First Quarter.
|
|
•
|
The net rate per patient visit was $103.00 in the 2022 First Quarter as compared to $104.72 in the 2021 First Quarter due to rate
reductions implemented by Medicare in 2022.
|
|
•
|
Net patient revenue from physical therapy operations was $109.5 million for the 2022 First Quarter, an increase of 10.4% from $99.3
million for the 2021 First Quarter.
|
|
•
|
Industrial injury prevention (“IIP”) services revenue was an all-time high of $19.1 million for the 2022 First Quarter, representing a
90.5% increase over the 2021 First Quarter. Excluding $6.8 million of revenue related to the November 2021 IIP acquisition, IIP services revenue increased 22.4% period over period.
|
|
•
|
Total revenue of $131.7 million for the 2022 First Quarter was 17.2% higher than total revenue of $112.4 million for the 2021 First
Quarter.
|
|
•
|
Physical therapy operating costs were $83.09 per visit in the 2022 First Quarter as compared to $81.18 in the 2021 First Quarter, an
increase of 2.4%. On a same store basis, physical therapy operating costs per visit increased 0.4% to $81.08 in the 2022 First Quarter from $80.78 in the 2021 First Quarter.
|
|
•
|
Total operating cost was 79.8% of total revenue in the 2022 First Quarter, as compared to 77.0% for the 2021 First Quarter. Total
salaries and related costs were 57.1% of total revenue for the 2022 First Quarter versus 56.8% for the 2021 First Quarter.
|
|
•
|
On March 31, 2022, the Company acquired 70.0% of the equity interest in a six-clinic physical therapy practice in South Central
Pennsylvania (Madden & Gilbert Physical Therapy, LLC). The business generates more than $7.5 million in annual revenue and has approximately 71,000 patient visits per year.
|
|
•
|
The Company’s Board of Directors declared a quarterly
dividend of $0.41 per share payable on June 14, 2022 to shareholders of record on May 16, 2022.
|
|
U.S. Physical Therapy Press Release
|
Page 2
|
|
May 5, 2022
|
|
|
•
|
Reported total revenue for the 2022 First Quarter was $131.7 million, an increase of 17.2% as compared to $112.4 million for the
2021 First Quarter. See table below for a detail of reported total revenue (in thousands):
|
|
Three Months Ended
|
||||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
Revenue related to Mature Clinics
|
$
|
102,321
|
$
|
98,649
|
||||
|
Revenue related to 2022 Clinic Additions
|
195
|
-
|
||||||
|
Revenue related to 2021 Clinic Additions
|
6,823
|
149
|
||||||
|
Revenue from clinics sold or closed in 2022
|
199
|
190
|
||||||
|
Revenue from clinics sold or closed in 2021
|
-
|
266
|
||||||
|
Net patient revenue from physical therapy operations
|
109,538
|
99,254
|
||||||
|
Other revenue
|
872
|
546
|
||||||
|
Revenue from physical therapy operations
|
110,410
|
99,800
|
||||||
|
Revenue from management contracts
|
2,226
|
2,559
|
||||||
|
Revenue from industrial injury prevention services
|
19,068
|
10,009
|
||||||
|
Total Revenue
|
$
|
131,704
|
$
|
112,368
|
||||
|
•
|
Revenue from physical therapy operations increased $10.6 million, or 10.6%, to $110.4 million for the 2022 First Quarter from
$99.8 million for the 2021 First Quarter. Net patient revenue related to clinics opened or acquired prior to 2021 and still in operation at March 31, 2022 (“Mature Clinics”) increased $3.7 million, or 3.7%, to $102.3 million for the
2022 First Quarter compared to $98.6 million for the 2021 First Quarter.
|
|
•
|
The average net patient revenue per visit was $103.00 for the 2022 First Quarter as compared to $104.72 for the 2021 First
Quarter. Total patient visits increased 12.2% to 1,063,519 for the 2022 First Quarter from 947,788 for the 2021 First Quarter. Visits for Mature Clinics (same store) for the 2022 First Quarter increased 5.9% as compared to the 2021
First Quarter.
|
|
•
|
Management contract revenue decreased 13.0% to $2.2 million for the 2022 First Quarter as compared to $2.6 million for the 2021
First Quarter.
|
|
•
|
IIP services revenue increased 90.5% to $19.1 million for the 2022 First Quarter as compared to $10.0 million for the 2021 First
Quarter. Excluding $6.8 million of revenue related to the IIP acquisition in November 2021, IIP services revenue increased 22.4% in the 2022 First Quarter as compared to the 2021 First Quarter
|
|
U.S. Physical Therapy Press Release
|
Page 3
|
|
May 5, 2022
|
|
|
•
|
Total operating cost was $105.1 million for the 2022 First Quarter, or 79.8% of total revenue, as compared to $86.5 million, or 77.0%
of total revenue, for the 2021 First Quarter. Operating cost related to Mature Clinics increased by $4.8 million for the 2022 First Quarter compared to the 2021 First Quarter. On a per visit basis, operating cost related to Mature
Clinics increased 0.4% from $80.78 in the 2021 First Quarter to $81.08 in the 2022 First Quarter. In addition, operating cost related to the industrial injury prevention services business increased by $7.6 million of which $5.6 million
related to the recent IIP acquisition. See table below for a detail of operating cost (in thousands):
|
|
Three Months Ended
|
||||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
Operating cost related to Mature Clinics
|
$
|
81,034
|
$
|
76,221
|
||||
|
Operating cost related to 2022 Clinic Additions
|
840
|
-
|
||||||
|
Operating cost related to 2021 Clinic Additions
|
6,209
|
136
|
||||||
|
Operating cost related to clinics sold or closed in 2022
|
286
|
249
|
||||||
|
Operating cost related to clinics sold or closed in 2021
|
-
|
334
|
||||||
|
Operating cost related to physical therapy operations
|
88,369
|
76,940
|
||||||
|
Operating cost related to management contracts
|
1,831
|
2,245
|
||||||
|
Operating cost related to industrial injury prevention services
|
14,916
|
7,287
|
||||||
|
Total operating cost
|
$
|
105,116
|
$
|
86,472
|
||||
|
|
||||||||
|
•
|
Total salaries and related costs, including all operations, were 57.1% of total revenue for the 2022 First Quarter versus 56.8% for
the 2021 First Quarter. Rent, supplies, contract labor and other costs as a percentage of total revenue were 21.8% for the 2022 First Quarter versus 19.1% for the 2021 First Quarter. The provision for credit losses as a percentage of
total revenue was 1.0% for 2022 First Quarter and 1.1% for 2021 First Quarter.
|
|
•
|
Gross profit for the 2022 First Quarter, was $26.6 million, an increase of $0.7 million, or approximately 2.7%, as compared to $25.9
million for the 2021 First Quarter. The gross profit percentage was 20.2% of total revenue for the 2022 First Quarter as compared to 23.0% for the 2021 First Quarter. The gross profit percentage for the Company’s physical therapy
operations was 20.0% for the 2022 First Quarter as compared to 22.9% for the 2021 First Quarter. The gross profit percentage on management contracts was 17.7% for the 2022 First Quarter as compared to 12.3% for the 2021 First Quarter.
The gross profit percentage for industrial injury prevention services was 21.8% for the 2022 First Quarter as compared to 27.2% for the 2021 First Quarter. The table below details the gross profit (in thousands):
|
|
Three Months Ended
|
||||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
|
||||||||
|
Physical therapy operations
|
$
|
22,041
|
$
|
22,860
|
||||
|
Management contracts
|
395
|
314
|
||||||
|
Industrial injury prevention services
|
4,152
|
2,722
|
||||||
|
Gross profit
|
$
|
26,588
|
$
|
25,896
|
||||
|
|
||||||||
|
|
||||||||
|
U.S. Physical Therapy Press Release
|
Page 4
|
|
May 5, 2022
|
|
|
•
|
Corporate office costs were $11.6 million for the 2022 First Quarter compared to $10.9 million for the 2021 First Quarter. Corporate
office costs were 8.8% of total revenue for the 2022 First Quarter as compared to 9.7% for the 2021 First Quarter.
|
|
•
|
Operating income for the 2022 First Quarter and 2021 First Quarter was $15.0 million. Operating income as a percentage of total
revenue was 11.4% for the 2022 First Quarter as compared to 13.4% for the 2021 First Quarter.
|
|
•
|
The gain on revaluation of put-right liability was $603,000. As part of the IIP business acquisition on November 30, 2021, the
Company also agreed to the potential future purchase of a separate company under the same ownership that provides physical therapy and rehabilitation services to hospitals and other ancillary providers in a distinct market area. The
owners have the right to put this transaction to the Company in approximately five years, with such right having a $2.9 million value at March 31, 2022, as reflected on the Company’s consolidated balance sheet in Other long-term
liabilities. The value of this right will continue to be adjusted in future periods, as appropriate,.
|
|
•
|
The provision for income tax was $3.5 million for the 2022 First Quarter and $2.9 million for the 2021 First Quarter. The provision
for income tax as a percentage of income before taxes less net income attributable to non-controlling interest (effective tax rate) was 28.6% for the 2022 First Quarter and 26.5% for the 2021 First Quarter. See table below ($ in
thousands):
|
|
Three Months Ended
|
||||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
Income before taxes
|
$
|
15,480
|
$
|
14,830
|
||||
|
Less: net income attributable to non-controlling interest:
|
||||||||
|
Redeemable non-controlling interest - temporary equity
|
(2,557
|
)
|
(2,453
|
)
|
||||
|
Non-controlling interest - permanent equity
|
(626
|
)
|
(1,260
|
)
|
||||
|
$
|
(3,183
|
)
|
$
|
(3,713
|
)
|
|||
|
Income before taxes less net income attributable to non-controlling interest
|
$
|
12,297
|
$
|
11,117
|
||||
|
Provision for income taxes
|
$
|
3,498
|
$
|
2,944
|
||||
|
Percentage
|
28.4
|
%
|
26.5
|
%
|
||||
|
•
|
Net income attributable to redeemable non-controlling interest (temporary equity) was $2.6 million for the 2022 First Quarter and $2.5
million for the 2021 First Quarter. Net income attributable to non-controlling interest (permanent equity) was $0.6 million for the 2022 First Quarter and $1.3 million for the 2021 First Quarter.
|
| U.S. Physical Therapy Press Release |
Page 5
|
|
May 5, 2022
|
|
| U.S. Physical Therapy Press Release |
Page 6
|
|
May 5, 2022
|
|
| U.S. Physical Therapy Press Release |
Page 7
|
|
May 5, 2022
|
|
|
Three Months Ended
|
||||||||
|
March 31, 2022
|
March 31, 2021
|
|||||||
|
Net patient revenue
|
$
|
109,538
|
$
|
99,254
|
||||
|
Other revenue
|
22,166
|
13,114
|
||||||
|
Net revenue
|
131,704
|
112,368
|
||||||
|
Operating cost:
|
||||||||
|
Salaries and related costs
|
75,149
|
63,815
|
||||||
|
Rent, supplies, contract labor and other
|
28,662
|
21,457
|
||||||
|
Provision for credit losses
|
1,305
|
1,200
|
||||||
|
Total operating cost
|
105,116
|
86,472
|
||||||
|
Gross profit
|
26,588
|
25,896
|
||||||
|
Corporate office costs
|
11,556
|
10,874
|
||||||
|
Operating income
|
15,032
|
15,022
|
||||||
|
Other income and expense
|
||||||||
|
Equity in earnings of unconsolidated affiliate
|
339
|
-
|
||||||
|
Interest and other income, net
|
46
|
54
|
||||||
|
Gain on revaluation of put-right liability
|
603
|
-
|
||||||
|
Interest expense - debt and other
|
(540
|
)
|
(246
|
)
|
||||
|
Total other income and expense
|
448
|
(192
|
)
|
|||||
|
Income before taxes
|
15,480
|
14,830
|
||||||
|
Provision for income taxes
|
3,498
|
2,944
|
||||||
|
Net income
|
11,982
|
11,886
|
||||||
|
Less: net income attributable to non-controlling interest:
|
||||||||
|
Redeemable non-controlling interest - temporary equity
|
(2,557
|
)
|
(2,453
|
)
|
||||
|
Non-controlling interest - permanent equity
|
(626
|
)
|
(1,260
|
)
|
||||
|
(3,183
|
)
|
(3,713
|
)
|
|||||
|
Net income attributable to USPH shareholders
|
$
|
8,799
|
$
|
8,173
|
||||
|
Basic and diluted earnings per share attributable to USPH shareholders
|
$
|
0.67
|
$
|
0.21
|
||||
|
Shares used in computation - basic and diluted
|
12,937
|
12,870
|
||||||
|
Dividends declared per common share
|
$
|
0.41
|
$
|
0.35
|
||||
|
U.S. Physical Therapy Press Release
|
Page 8
|
|
May 5, 2022
|
|
|
March 31, 2022
|
December 31, 2021
|
||||||
|
ASSETS
|
(unaudited)
|
|||||||
|
Current assets:
|
||||||||
|
Cash and cash equivalents
|
$
|
24,229
|
$
|
28,567
|
||||
|
Patient accounts receivable, less allowance for credit losses of $2,799 and $2,768, respectively
|
49,335
|
46,272
|
||||||
|
Accounts receivable - other
|
18,239
|
16,144
|
||||||
|
Other current assets
|
4,040
|
4,183
|
||||||
|
Total current assets
|
95,843
|
95,166
|
||||||
|
Fixed assets:
|
||||||||
|
Furniture and equipment
|
60,205
|
58,743
|
||||||
|
Leasehold improvements
|
40,541
|
39,194
|
||||||
|
Fixed assets, gross
|
100,746
|
97,937
|
||||||
|
Less accumulated depreciation and amortization
|
76,601
|
74,958
|
||||||
|
Fixed assets, net
|
24,145
|
22,979
|
||||||
|
Operating lease right-of-use assets
|
94,243
|
96,427
|
||||||
|
Investment in unconsolidated affiliate
|
12,422
|
12,215
|
||||||
|
Goodwill
|
443,692
|
434,679
|
||||||
|
Other identifiable intangible assets, net
|
91,546
|
86,382
|
||||||
|
Other assets
|
1,972
|
1,578
|
||||||
|
Total assets
|
$
|
763,863
|
$
|
749,426
|
||||
|
|
||||||||
|
LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST, USPH SHAREHOLDERS’ EQUITY AND NON-CONTROLLING INTEREST
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable - trade
|
$
|
3,272
|
$
|
3,268
|
||||
|
Accounts payable - due to seller of acquired business
|
3,203
|
3,203
|
||||||
|
Accrued expenses
|
51,121
|
45,705
|
||||||
|
Current portion of operating lease liabilities
|
30,625
|
30,475
|
||||||
|
Current portion of notes payable
|
799
|
830
|
||||||
|
Total current liabilities
|
89,020
|
83,481
|
||||||
|
Notes payable, net of current portion
|
4,128
|
3,587
|
||||||
|
Revolving line of credit
|
118,000
|
114,000
|
||||||
|
Deferred taxes
|
16,067
|
14,385
|
||||||
|
Operating lease liabilities, net of current portion
|
72,162
|
74,185
|
||||||
|
Other long-term liabilities
|
4,262
|
7,345
|
||||||
|
Total liabilities
|
303,639
|
296,983
|
||||||
|
|
||||||||
|
Redeemable non-controlling interest - temporary equity
|
158,008
|
155,262
|
||||||
|
|
||||||||
|
Commitments and Contingencies
|
||||||||
|
|
||||||||
|
U.S. Physical Therapy, Inc. ("USPH") shareholders’ equity:
|
||||||||
|
Preferred stock, $.01 par value, 500,000 shares authorized, no shares issued and outstanding
|
-
|
-
|
||||||
|
Common stock, $.01 par value, 20,000,000 shares authorized,
|
||||||||
|
15,206,173 and 15,126,160 shares issued, respectively
|
151
|
151
|
||||||
|
Additional paid-in capital
|
105,205
|
102,688
|
||||||
|
Retained earnings
|
227,243
|
224,395
|
||||||
|
Treasury stock at cost, 2,214,737 shares
|
(31,628
|
)
|
(31,628
|
)
|
||||
|
Total USPH shareholders’ equity
|
300,971
|
295,606
|
||||||
|
Non-controlling interest - permanent equity
|
1,245
|
1,575
|
||||||
|
Total USPH shareholders' equity and non-controlling interest - permanent equity
|
302,216
|
297,181
|
||||||
|
Total liabilities, redeemable non-controlling interest,
|
||||||||
|
USPH shareholders' equity and non-controlling interest - permanent equity
|
$
|
763,863
|
$
|
749,426
|
||||
|
|
||||||||
|
U.S. Physical Therapy Press Release
|
Page 9
|
|
May 5, 2022
|
|
|
Three Months Ended
|
|||||||
|
|
March 31, 2022
|
March 31, 2021
|
||||||
|
OPERATING ACTIVITIES
|
||||||||
|
Net income including non-controlling interest and earnings from unconsolidated affiliates, net
|
$
|
11,982
|
$
|
11,886
|
||||
|
Adjustments to reconcile net income including non-controlling interest to net cash provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
3,824
|
2,681
|
||||||
|
Provision for credit losses
|
1,305
|
1,200
|
||||||
|
Equity-based awards compensation expense
|
1,846
|
1,651
|
||||||
|
Deferred income taxes
|
2,132
|
2,181
|
||||||
|
Gain on revaluation of put-right liability
|
(603
|
)
|
-
|
|||||
|
Earnings in unconsolidated affiliate
|
(339
|
)
|
-
|
|||||
|
Other
|
93
|
96
|
||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Increase in patient accounts receivable
|
(4,676
|
)
|
(4,688
|
)
|
||||
|
(Increase) decrease in accounts receivable - other
|
(2,145
|
)
|
220
|
|||||
|
(Increase) decrease in other assets
|
(735
|
)
|
221
|
|||||
|
Increase in accounts payable and accrued expenses
|
1,445
|
3,969
|
||||||
|
Decrease in other long-term liabilities
|
(2,480
|
)
|
(1,743
|
)
|
||||
|
Net cash provided by operating activities
|
11,649
|
17,674
|
||||||
|
|
||||||||
|
INVESTING ACTIVITIES
|
||||||||
|
Purchase of fixed assets
|
(2,528
|
)
|
(1,608
|
)
|
||||
|
Purchase of majority interest in businesses, net of cash acquired
|
(11,242
|
)
|
(11,747
|
)
|
||||
|
Purchase of redeemable non-controlling interest, temporary equity
|
(2,211
|
)
|
||||||
|
Purchase of non-controlling interest, permanent equity
|
(99
|
)
|
||||||
|
Proceeds on sales of partnership interest, clinics and fixed assets
|
4
|
152
|
||||||
|
Distributions from unconsolidated affiliate
|
132
|
-
|
||||||
|
Sales of non-controlling interest-permanent
|
-
|
-
|
||||||
|
Net cash used in investing activities
|
(15,944
|
)
|
(13,203
|
)
|
||||
|
|
||||||||
|
FINANCING ACTIVITIES
|
||||||||
|
Distributions to non-controlling interest, permanent and temporary equity
|
(3,711
|
)
|
(5,265
|
)
|
||||
|
Cash dividends paid to shareholders
|
-
|
-
|
||||||
|
Proceeds from revolving line of credit
|
35,000
|
60,000
|
||||||
|
Payments on revolving line of credit
|
(31,000
|
)
|
(60,000
|
)
|
||||
|
Principal payments on notes payable
|
(332
|
)
|
(145
|
)
|
||||
|
(Payment) receipt of Medicare Accelerated and Advance Funds
|
-
|
(14,054
|
)
|
|||||
|
Other
|
-
|
12
|
||||||
|
Net cash used in financing activities
|
(43
|
)
|
(19,452
|
)
|
||||
|
|
||||||||
|
Net decrease in cash and cash equivalents
|
(4,338
|
)
|
(14,981
|
)
|
||||
|
Cash and cash equivalents - beginning of period
|
28,567
|
32,918
|
||||||
|
Cash and cash equivalents - end of period
|
$
|
24,229
|
$
|
17,937
|
||||
|
|
||||||||
|
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
|
||||||||
|
Cash paid during the period for:
|
||||||||
|
Income taxes
|
$
|
81
|
$
|
62
|
||||
|
Interest paid
|
$
|
525
|
$
|
298
|
||||
|
Non-cash investing and financing transactions during the period:
|
||||||||
|
Purchase of businesses - seller financing portion
|
$
|
300
|
$
|
300
|
||||
|
Notes payable related to purchase of redeemable non-controlling interest, temporary equity
|
$
|
246
|
$
|
4,829
|
||||
|
Notes payable due to purchase of non-controlling interest, permanent equity
|
$
|
296
|
$
|
-
|
||||
|
Notes receivable related to sale of partnership interest - redeemable non-controlling interest
|
$
|
-
|
$
|
287
|
||||
|
Dividends payable to USPH shareholders
|
$
|
5,327
|
$
|
4,514
|
||||
|
|
||||||||
|
U.S. Physical Therapy Press Release
|
Page 10
|
|
May 5, 2022
|
|
U.S. Physical Therapy Press Release
|
Page 11
|
|
May 5, 2022
|
|
|
Three Months Ended March 31,
|
|||||||
|
|
2022
|
2021
|
||||||
|
Computation of earnings per share - USPH shareholders:
|
||||||||
|
Net income attributable to USPH shareholders
|
$
|
8,799
|
$
|
8,173
|
||||
|
Credit (charges) to retained earnings:
|
||||||||
|
Revaluation of redeemable non-controlling interest
|
(153
|
)
|
(7,270
|
)
|
||||
|
Tax effect at statutory rate (federal and state) of 25.55%
|
39
|
1,857
|
||||||
|
$
|
8,685
|
$
|
2,760
|
|||||
|
Earnings per share (basic and diluted)
|
$
|
0.67
|
$
|
0.21
|
||||
|
|
||||||||
|
Adjustments:
|
||||||||
|
Gain on revaluation of put-right liability
|
(603
|
)
|
-
|
|||||
|
Revaluation of redeemable non-controlling interest
|
153
|
7,270
|
||||||
|
Tax effect at statutory rate (federal and state)
|
115
|
(1,857
|
)
|
|||||
|
Operating Results (a non-GAAP measure)
|
$
|
8,350
|
$
|
8,173
|
||||
|
Basic and diluted Operating Results per share (a non-GAAP measure)
|
$
|
0.65
|
$
|
0.64
|
||||
|
Shares used in computation - basic and diluted
|
12,937
|
12,870
|
||||||
|
|
Three Months Ended March 31,
|
|||||||
|
|
2022
|
2021
|
||||||
|
|
||||||||
|
Net income attributable to USPH shareholders
|
$
|
8,799
|
$
|
8,173
|
||||
|
|
||||||||
|
Adjustments:
|
||||||||
|
Depreciation and amortization
|
3,824
|
2,681
|
||||||
|
Interest income
|
(46
|
)
|
(54
|
)
|
||||
|
Gain on revaluation of put-right liability
|
(603
|
)
|
-
|
|||||
|
Interest expense - debt and other
|
540
|
247
|
||||||
|
Provision for income taxes
|
3,498
|
2,944
|
||||||
|
Equity-based awards compensation expense
|
1,846
|
1,651
|
||||||
|
Adjusted EBITDA (a non-GAAP measure)
|
$
|
17,858
|
$
|
15,642
|
||||
|
U.S. Physical Therapy Press Release
|
Page 12
|
|
May 5, 2022
|
|
Date
|
Number of Clinics
|
|
March 31, 2021
|
564
|
|
June 30, 2021
|
575
|
|
September 30, 2021
|
579
|
|
December 31, 2021
|
591
|
|
March 31, 2022
|
601
|